T099: High efficacy and durability of second-line therapy with pembrolizumab, gemcitabine, vinorelbine, and liposomal doxorubicin in the phase II study for relapsed and refractory Hodgkin lymphoma

Enregistré dans:

Détails bibliographiques
Auteurs principaux:	Alison J. Moskowitz, Gunjan Shah, Heiko Schöder, Nivetha Ganesan, Helen Hancock, Theresa Davey, Leslie Perez, Samia Sohail, Alayna Santarosa, Charisse Capadona, Brittney Munayirji, Anita Kumar, Oscar Lahoud, Connie Batlevi, Paul Hamlin, David J. Straus, Colette Owens, Philip Caron, Andrew Intlekofer, Audrey Hamilton, Steven Horwitz, Lorenzo Falchi, William Johnson, Lia Palomba, Ariela Noy, Matthew Matasar, Georgios Pongas, Gilles Salles, Santosha Vardhana, Beatriz Wills Sanin, Joachim Yahalom, Ahmet Dogan, Andrew Zelenetz, Craig H. Moskowitz
Format:	Artigo
Langue:	Inglês
Publié:	Wiley 2022-10-01
Collection:	HemaSphere
Accès en ligne:	http://journals.lww.com/10.1097/01.HS9.0000890964.54059.2c
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires